NCT07482722

Brief Summary

This study aims to evaluate the effectiveness of a virtual reality (VR)-based transitional care program for adult survivors of intensive care unit (ICU) care. ICU survivors frequently experience relocation stress, anxiety, pain, and physiological instability after transfer from the ICU to general wards, which may increase the risk of unplanned ICU readmission. Participants will be randomly assigned to receive either standard transitional care or additional VR-based intervention sessions during their ICU stay. The VR intervention is designed to provide psychological support, environmental orientation, and stress reduction. Primary outcomes include short-term physiological indicators within 48 hours after ICU transfer. Secondary outcomes include pain, relocation stress, and unplanned ICU readmission within 7 days.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Mar 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Mar 2026Feb 2027

First Submitted

Initial submission to the registry

March 3, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

March 9, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

March 3, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Virtual RealityICU SurvivorsRelocation StressHeart Rate VariabilityTransitional CareUnplanned ICU ReadmissionRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Heart Rate Variability - RMSSD

    Heart rate variability measured using the Root Mean Square of Successive Differences (RMSSD) derived from electrocardiographic recordings.

    Within 48 hours after transfer from the ICU to the general ward

  • Heart Rate Variability - High Frequency Power

    Heart rate variability measured using high-frequency (HF) power derived from electrocardiographic recordings.

    Within 48 hours after transfer from the ICU to the general ward

Secondary Outcomes (3)

  • Pain Intensity

    Within 48 hours after ICU transfer

  • Unplanned ICU Readmission

    Within 7 days after ICU transfer

  • Relocation Stress

    Within 48 hours after ICU transfer

Study Arms (2)

VR Intervention Group

EXPERIMENTAL

Participants receive standard transitional care plus three VR sessions during ICU stay.

Behavioral: Virtual Reality-Based Transitional Care

Standard Care Group

NO INTERVENTION

Participants receive standard ICU transitional care without VR intervention.

Interventions

Participants assigned to this arm will receive three structured virtual reality (VR) sessions during their ICU stay in addition to standard transitional care. Each VR session is designed to provide environmental orientation, psychological support, and stress reduction through immersive audiovisual content. The intervention aims to improve short-term physiological stability and reduce relocation stress following ICU transfer.

VR Intervention Group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20 years or older
  • Adult patients admitted to the intensive care unit (ICU)
  • Planned transfer from ICU to the general ward
  • Able to communicate and provide informed consent or have a legal representative provide consent

You may not qualify if:

  • Severe cognitive impairment or delirium preventing participation
  • Severe visual or hearing impairment interfering with VR use
  • Hemodynamic instability requiring immediate life-saving intervention
  • Isolation precautions prohibiting device use
  • Participation in another interventional study that may affect outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

MacKay Memorial Hospital

Taipei, Taipei City, 104, Taiwan

Location

MacKay Memorial Hospital, Tamsui Branch

New Taipei City, 251, Taiwan

Location

MeSH Terms

Conditions

Critical IllnessStress, Psychological

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Te-Yu Wu, PhD

    MacKay Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Ling Yang, RN, NP

CONTACT

Yu-Ling Yang, RN, NP

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to either the VR intervention group or the standard care control group using block randomization.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MacKay Medical University

Study Record Dates

First Submitted

March 3, 2026

First Posted

March 19, 2026

Study Start

March 9, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations